Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 68 of 1,261
  1. CN 119343336

    1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents

    BRACCO IMAGING SPA · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  2. US 12201591

    Sustained release compositions of endoxifen

    ATOSSA THERAPEUTICS, INC. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  3. US 12201598

    Immunoregulatory microparticles for modulating inflammatory arthritides

    The Regents of the University of California · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  4. US 12202797

    Method for producing pyrrole compound

    Takeda Pharmaceutical Company Limited · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  5. US 12201683

    Methods for preventing dengue and hepatitis a

    Takeda Vaccines, Inc. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  6. US 12201685

    Methods of modulating immune responses with cationic lipid vaccine compositions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  7. US 12202895

    LILRB4 antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  8. US 12201593

    Oral pharmaceutical formulations of bitter compounds for asthma

    Aardvark Therapeutics, Inc. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  9. US 12203143

    Methods and kits to identify Klebsiella strains

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  10. US 12201601

    Treatment for obesity

    AXSOME MALTA LTD. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  11. US 12201617

    HDAC6 inhibitors for treatment of metabolic disease and HFpEF

    Tenaya Therapeutics, Inc. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  12. US 12201604

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  13. US 12201673

    Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  14. US 12201719

    Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy

    VACCINEX, INC. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  15. US 12201453

    Microneedle fabrication and device implantation

    The Regents of the University of California · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  16. US 12201596

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  17. US 12201655

    Antimicrobial therapy

    The Regents of the University of California · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  18. CN 119325492

    Fluorescent probe targeting CA-IX

    BRACCO IMAGING SPA · Granted Jan 17, 2025 · Expires Jan 12, 2045

    granted
  19. US 12194082

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  20. US 12195447

    Azolopyrimidine for the treatment of cancer-related disorders

    Arcus Biosciences, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  21. US 12194064

    Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids

    Aker BioMarine Human Ingredients AS · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  22. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  23. US 12194061

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  24. US 12195768

    System and method for modulating stress granule assembly

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.